Abstract
Aim:
To observe the efficacy and safety of Rocaltrol (calcitriol) and/or Caltrate D (calicum carbonate plus vitamin D) in elderly Chinese women with osteopenia or osteoporosis.
Methods:
One hundred fifty Chinese women aged over 65 years with osteopenia or osteoporosis from three centers were randomly divided into two groups. Seventy-six participants received Caltrate D as one pill daily; the other 74 participants received 0.25 μg Caltrate D plus Rocaltrol daily. The changes in bone mineral density (BMD) served as primary end-points. Height changes, the presence of new vertebral fractures, muscle strength and balance were evaluated.
Results:
The following are the mean percentage changes (and SD) in BMD over 12 months: at L2-L4, 0.83±3.88 in the Caltrate D group and 2.84±4.04 in the Rocaltrol+Caltrate D group (P=0.003, by ANCOVA); at the femoral neck, 0.04±3.94 in the Caltrate D group and 2.01±5.45 in the Rocaltrol+Caltrate D group (P=0.085, by ANCOVA); and in the trochanter, 1.59±4.57 in the Caltrate D group and 3.76±6.25 in the Rocaltrol+Caltrate D group (P=0.053, by ANCOVA). The stand and maximal forward reach test (SMFRT) was significantly enhanced in both groups during the 12 months of treatment, but no significant differences were found between these two groups. No severe adverse event related to these medications occurred throughout the study.
Conclusion:
Treatment with Rocaltrol plus Caltrate D or Caltrate D for 12 months in elderly Chinese postmenopausal women effectively increased BMD at the lumbar spine. Rocaltrol plus Caltrate D was more effective at the lumbar spine than Caltrate D alone.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785–95.
Boonen S, Vanderschueren D, Haentjens P, Lips P . Calcium and vitamin D in the prevention and treatment of osteoporosis — a clinical update. J Intern Med 2006; 59: 539–52.
Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ . Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. J Clin Endocrinol Metab 1996; 81: 1129–33.
Mingrone G, Greco AV, Castagneto M, Gasbarrini G . A woman who left her wheel chair. Lancet 1999; 353: 806.
Prabhala A, Garg R, Dandona P . Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 2000; 160: 1199–203.
Holick MF . Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.
Pei Y, Zhou XY, Meng XW, Xia WB, Xing XP, Liu HC, et al. Interaction effects between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta1 on the proliferation and differentiation of human embryonic osteoblasts. Zhonghua Yi Xue Za Zhi 2003; 83: 1084–8.(Chinese).
Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, et al. Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002; 23: 560–9.
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B . Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257–64.
Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996; 11: 984–96.
Rantanen T, Masaki K, Foley D, Izmirlian G, White L, Guralnik JM . Grip strength changes over 27 yr in Japanese-American men. J Appl Physiol 1998; 85: 2047–53.
Whitney SL, Wrisley DM, Marchetti GF, Gee MA, Redfern MS, Furman JM . Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the five-times-sit-to-stand test. Phys Ther 2005; 85: 1034–45.
Newton RA . Validity of the multi-directional reach test: a practical measure of limits of stability in older adults. J Gerontol A Biol Sci Med Sci 1997; 56A: M248–252.
Cooper C, Campion G, Melton LJ . Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992; 2: 25–9.
Marcus R, Wong M, Heath H 3rd, Stock JL. Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocrine Rev 2002; 23: 16–37.
Baeksgaard L, Anderson KP, Hyldstrup L . Calcium and vitamin D supplementation increase spinal BMD in healthy postmenopausal women. Osteoporos Int 1998; 8: 255–60.
Liu XY, Zhao XH, Xu L . Food sources of calcium and iron in the diet of Beijing elderly. J Hygiene Res 2004; 33: 336–8. (Chinese).
Zhou XY, Meng XW, Liu SQ, Chen SS, Song LQ . The study of serum 25-hydroxyvitamin D levels between the people living in Lhasa area in Tibet and Beijing area. Natl Med J China 1995; 75: 261. (Chinese).
Häuselmann HJ, Rizzoli R . A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 2003; 14: 2–12.
Sairanen S, Kärkkäinen M, Tähtelä R, Laitinen K, Mäkelä P, Lamberg-Allardt C, et al. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years. Calcif Tissue Int 2000; 67: 122–7.
Shah D, Shroff S, Jankharia B, Parihar A . Effects of calcitriol (Rocaltrol) on spine and femoral neck bone mineral density in postmenopausal osteoporosis. Bombay Hosp J 2002; 44: 236–41.
Venning G . Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ 2005; 330: 524–6.
Dawson-Hughes B, Harris SS, Krall EA, Dallal GE . Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337: 670–6.
Tilyard MW, Spears GF, Thomson J, Dovey S . Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992; 326: 357–62.
Acknowledgements
This work was supported by the Key Technologies R & D Program under grant No 2006BAI02B03 and the National Natural Science Foundation of China (NSFC) under grant No 30370781.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xia, Wb., Zhang, Zl., Wang, Hf. et al. The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass. Acta Pharmacol Sin 30, 372–378 (2009). https://doi.org/10.1038/aps.2009.12
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2009.12
Keywords
This article is cited by
-
US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study
European Radiology (2019)
-
The three different types of paleokarstification and reservoir distribution of Leikoupo Formation, Middle Triassic in the northern Sichuan Basin, China
Carbonates and Evaporites (2018)
-
Differences between the platform-margin shoal reservoirs and the platform-interior shoal reservoirs of the Middle Triassic Leikoupo Formation, Sichuan Basin, China
Carbonates and Evaporites (2014)
-
Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency
Acta Pharmacologica Sinica (2012)
-
General depositional features of the carbonate platform gas reservoir of the Lower Triassic Jialingjiang Formation in the Sichuan Basin of southwest China: Moxi gas field of the central basin
Carbonates and Evaporites (2011)
